• 1. An amphipathic trans-acting phosphorothioate RNA element delivers an uncharged phosphorodiamidate morpholino sequence in mdx mouse myotubes?
  H. V. Jain,D. Verthelyi,S. L. Beaucage RSC Adv., 2017,7, 42519-42528
• 2. An atomistic mechanism for the degradation of perovskite solar cells by trapped charge?
  Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378
• 3. An amorphous carbon nitride/NiO/CoN-based composite: a highly efficient nonprecious electrode for supercapacitors and the oxygen evolution reaction?
  Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034
• 4. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
• 5. An aqueous ammonia sensor based on an inkjet-printed polyaniline nanoparticle-modified electrode
  Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzyl alkyl sulfoxides
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzyl sulfoxides Benzyl alkyl sulfoxides

Introduction to 1-(4-CHLOROPHENYL)-2-[(4-METHOXYBENZYL)SULFINYL]-1-ETHANONE O-METHYLOXIME (CAS No. 320422-62-6)

1-(4-CHLOROPHENYL)-2-[(4-METHOXYBENZYL)SULFINYL]-1-ETHANONE O-METHYLOXIME (CAS No. 320422-62-6) is a complex organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, often referred to by its systematic name, is a derivative of oxime and features a unique structural arrangement that includes a chlorophenyl, methoxybenzyl, and sulfinyl functional groups. The intricate molecular structure of this compound endows it with a range of potential biological activities, making it a subject of extensive study in the development of novel therapeutic agents.

The chemical structure of 1-(4-CHLOROPHENYL)-2-[(4-METHOXYBENZYL)SULFINYL]-1-ETHANONE O-METHYLOXIME is characterized by its multifaceted functional groups. The presence of the chlorophenyl group imparts lipophilic properties, which can enhance the compound's ability to cross biological membranes. The methoxybenzyl group contributes to the compound's stability and solubility, while the sulfinyl group adds reactivity and potential for forming stable complexes with metal ions. The oxime functionality is known for its ability to form hydrogen bonds, which can influence the compound's interactions with biological targets.

In recent years, significant advancements have been made in understanding the biological activities of compounds like 1-(4-CHLOROPHENYL)-2-[(4-METHOXYBENZYL)SULFINYL)-1-ETHANONE O-METHYLOXIME. Research has shown that this compound exhibits potent antioxidant properties, which can be attributed to its ability to scavenge free radicals and protect cellular components from oxidative damage. Additionally, studies have demonstrated that this compound has anti-inflammatory effects, making it a promising candidate for the treatment of inflammatory diseases.

The pharmacological profile of 1-(4-CHLOROPHENYL)-2-[(4-METHOXYBENZYL)SULFINYL)-1-ETHANONE O-METHYLOXIME has also been explored in various preclinical models. In vitro studies have shown that this compound can inhibit the activity of specific enzymes involved in inflammatory pathways, such as cyclooxygenase (COX) and lipoxygenase (LOX). These findings suggest that the compound may have therapeutic potential in conditions characterized by chronic inflammation, such as arthritis and inflammatory bowel disease.

Beyond its anti-inflammatory properties, research has also highlighted the potential antitumor effects of 1-(4-CHLOROPHENYL)-2-[(4-METHOXYBENZYL)SULFINYL)-1-ETHANONE O-METHYLOXIME. Studies have demonstrated that this compound can induce apoptosis in cancer cells and inhibit tumor growth in animal models. The mechanism behind these effects is thought to involve the modulation of signaling pathways that regulate cell survival and proliferation. These findings have sparked interest in further investigating the compound's potential as an anticancer agent.

The structural complexity of 1-(4-CHLOROPHENYL)-2-[(4-METHOXYBENZYL)SULFINYL)-1-ETHANONE O-METHYLOXIME also makes it an attractive candidate for drug design and optimization. Chemists and pharmacologists are exploring ways to modify the compound's structure to enhance its potency, selectivity, and pharmacokinetic properties. For example, substituting different functional groups on the chlorophenyl or methoxybenzyl moieties can lead to compounds with improved biological activities or reduced side effects.

In addition to its therapeutic potential, 1-(4-CHLOROPHENYL)-2-[(4-METHOXYBENZYL)SULFINYL)-1-ETHANONE O-METHYLOXIME has been studied for its use as a chemical probe in biological research. Its unique structure allows it to interact with specific proteins or enzymes, making it a valuable tool for understanding molecular mechanisms underlying various diseases. For instance, researchers have used this compound to investigate the role of certain enzymes in inflammation and cancer progression.

The synthesis of 1-(4-CHLOROPHENYL)-2-[(4-METHOXYBENZYL)SULFINYL)-1-ETHANONE O-METHYLOXIME involves multiple steps and requires careful control over reaction conditions to ensure high yield and purity. Common synthetic routes include the formation of the ketone intermediate followed by conversion to the oxime using hydroxylamine derivatives. The sulfinyl group is typically introduced through sulfonation reactions or by reacting sulfinate salts with appropriate substrates.

In conclusion, 1-(4-CHLOROPHENYL)-2-[(4-METHOXYBENZYL)SULFINYL)-1-ETHANONE O-METHYLOXIME (CAS No. 320422-62-6) is a multifaceted organic compound with a range of potential applications in medicinal chemistry and pharmaceutical research. Its unique structural features and biological activities make it an exciting subject for further investigation and development as a therapeutic agent. As research continues to uncover new insights into its mechanisms of action and potential uses, this compound is poised to play a significant role in advancing our understanding and treatment of various diseases.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)